16-hydroxyestrone has been researched along with Pulmonary Hypertension in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Austin, ED; Chen, X; Cogan, JD; Dawson, EP; Fessel, JP; French, J; Gladson, S; Hamid, R; Hedges, LK; Hemnes, AR; Loyd, JE; Majka, SJ; Martinez, EG; Phillips, JA; Shay, S; Talati, M; Trammell, A; West, J; Wheeler, LA; Womble, KE | 1 |
| Campbell, A; Ciuclan, L; Johansen, AK; Loughlin, L; MacLean, MR; Mair, KM; McClure, JD; Morecroft, I; Nilsen, M; Paton, L; Thomas, M; Wallace, E; White, K | 1 |
2 other study(ies) available for 16-hydroxyestrone and Pulmonary Hypertension
| Article | Year |
|---|---|
Estrogen Metabolite 16α-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II-Associated Pulmonary Arterial Hypertension Through MicroRNA-29-Mediated Modulation of Cellular Metabolism.
Topics: Animals; Bone Morphogenetic Protein Receptors, Type II; Cellular Microenvironment; Female; Humans; Hydroxyestrones; Hypertension, Pulmonary; Male; Mice; Mice, Transgenic; MicroRNAs | 2016 |
Activity of the estrogen-metabolizing enzyme cytochrome P450 1B1 influences the development of pulmonary arterial hypertension.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Cell Hypoxia; Cells, Cultured; Chronic Disease; Cytochrome P-450 CYP1B1; Enzyme Induction; Estradiol; Estrogens; Female; Humans; Hydroxyestrones; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Lung; Male; Mice; Mice, Knockout; Myocytes, Smooth Muscle; Pulmonary Artery; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes; Up-Regulation | 2012 |